NEW YORK (GenomeWeb) — Roche said today that it has received CE marking for the cobas 6800/8800 automated molecular testing systems for blood and plasma donor screening.

The systems are now commercially available in all markets accepting the CE mark in Europe, Latin America, Middle East, Africa, and Asia.

Each system provides results for the first 96 tests in less than 3.5 hours, with the cobas 6800 delivering up to 384 results in an eight-hour shift, and the cobas 8800 generating up to 960 results in the same amount of time, Roche said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.